Moreover, studies have shown an increase in ACE2-expressing extracellular vesicles (evACE2) in the plasma of COVID-19 patients [93], which has been associated with immune response, inflammation, coagulation pathways, and pathology-related clinical indicators [91,94]. This evidence concerns the gene ACE2 and COVID-19.